Gainesville, FL – Antibiotic Adjuvant has been selected as a finalist for the Cade Prize to be held September 29, 2018. The Cade Prize serves to identify, recognize, and celebrate inventive minds and innovation in the state of Florida. Since its launch in 2010, the Cade Prize competition has drawn applications from hundreds of creative thinkers and cutting-edge ventures in IT, healthcare, biomedicine, environmental science, and agriculture, to name a few.
“We are very excited to be among such a distinguished group of startups,” remarks David Flores, CEO of Antibiotic Adjuvant. “After completing IndieBio in April, we have been actively looking for pitching competitions in Florida to build relationships with investors,” mentions Flores about their fundraising efforts and how they see this competition helping their digital health startup.
Out of the 100+ submissions, 16 have been selected to be the Sweet 16. For 2018, cash prizes will be awarded to the top four rankings. The Final Four will be named at the 4th annual Inventivity Bash. First place will be awarded $25,000, second place $15,000, third place $7,500, and fourth place $2,500.
About Antibiotic Adjuvant: Antibiotic Adjuvant is a digital health startup addressing the problem of antibiotic misuse to reduce antibiotic resistance, improve patient outcomes, and reduce the patient cost of care. Our first product, SmartSteward, optimizes antibiotic use on skilled nursing facilities. We have 3 active pilots and are finishing our minimum viable product.
About the Cade Museum: In 2004, Dr. James Robert Cade and his family established the Cade Museum Foundation to design and build a museum in Gainesville, Florida. The mission of the museum is to transform communities by inspiring and equipping future inventors, entrepreneurs, and visionaries. Dr. Cade, a physician at the University of Florida, was best known as the leader of the research team that invented Gatorade in 1965.